請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/6445
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 歐陽彥正 | |
dc.contributor.author | Ding-Dar Lee | en |
dc.contributor.author | 李定達 | zh_TW |
dc.date.accessioned | 2021-05-16T16:29:47Z | - |
dc.date.available | 2015-09-06 | |
dc.date.available | 2021-05-16T16:29:47Z | - |
dc.date.copyright | 2013-09-06 | |
dc.date.issued | 2013 | |
dc.date.submitted | 2013-08-17 | |
dc.identifier.citation | 1. Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006. Jih JS, Chen YJ, Lin MW, Chen YC, Chen TJ, Huang YL, Chen CC, Lee DD, Chang YT, Wang WJ, Liu HN. Acta Derm Venereol. 2009;89(6):612-6.
2. Pain, medication use, and health related quality of life in older persons with postherpetic neuralgia: results from a population based survey. Oster G, Harding G, Dukes E, Edelsberg J, Cleary PD. J Pain. 2005;6:356-63. 3. Acute pain in herpes zoster and its impact on health-related quality of life. Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Clin Infect Dis. 2004;39:342-8. 4. Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia. Gilden D. J Intern Med. 2011;269(5):496–506. 5. What does epidemiology tell us about risk factors for herpes zoster? Thomas SL, Hall AJ. Lancet Infect Dis. 2004;4:26–33. 6. Risk of herpes zoster among patients with psychiatric diseases: a population-based study. Yang YW, Chen YH, Lin HW. J Eur Acad Dermatol Venereol. 2011;25(4):447-53. 7. Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study. Yang YW, Chen YH, Wang KH, Wang CY, Lin HW. CMAJ. 2011;183(5):E275-80. 8. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, Chan KA. Arthritis Rheum. 2007;57(8):1431-8. 9. Risk of Herpes Zoster in CKD: A Matched-Cohort Study Based on Administrative Data. Wu MY, Hsu YH, Su CL, Lin YF, Lin HW. Am J Kidney Dis. 2012;60(4):548-52. 10. Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort. Chen HH, Chen YM, Chen TJ, Lan JL, Lin CH, Chen DY. Clinics (Sao Paulo). 2011;66(7):1177-82. 11. Risk of herpes zoster in patients treated with long-term hemodialysis: a matched cohort study. Kuo CC, Lee CT, Lee IM, Ho SC, Yang CY. Am J Kidney Dis. 2012;59(3):428-33. 12. Management of the patient with suspected temporal arteritis: a decision-analytic approach. Niederkohr RD, Levin LA. Ophthalmology. 2005;112:744-56. 13. Decision tree classification of proteins identified by mass spectrometry of blood serum samples from people with and without lung cancer. Markey MK, Tourassi GD, Floyd CE, Jr. Proteomics. 2003;3:1678-9. 14. The burden of herpes zoster and postherpetic neuralgia in the United States. Weaver BA. J Am Osteopath Assoc. 2007;107(3 Suppl 1):S2-7. 15. Vaccination: a new option to reduce the burden of herpes zoster. Mick G. Expert Rev. Vaccines. 2010; 9(3 Suppl.):31–5. 16. Herpes zoster and quality of life: a self-limited disease with severe impact.Lydick E, Epstein RS, Himmelberger D, et al. Neurology. 1995;45:S52-3. 17. Measurement of pain. Katz J, Melzack R. Surg Clin North Am 1999;79:231-52. 18. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Lin HC, Chien CW, Ho JD. Neurology. 2010;74(10):792-7. 19. Herpes zoster: epidemiology, natural history, and common complications. Weinberg JM. J Am Acad Dermato. 2007;57(6 Suppl):S130-5. 20. Schmader K, Studenski S, MacMillan J, Grufferman S, Cohen HJ. Are stressful life events risk factors for herpes zoster? J Am Geriatr Soc. 1990;38:1188-94. 21. Seasonal variation in herpes zoster infection. Gallerani M, Manfredini R. Br J Dermatol. 2000;142(3):588-9. 22. Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture. Toyama N, Shiraki K; Society of the Miyazaki Prefecture Dermatologists. J Med Virol. 2009;81(12):2053-8. 23. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Brisson M, Edmunds WJ, Law B, Gay NJ, Walld R, Brownell M, Roos L, De Serres G. Epidemiol Infect. 2001;127(2):305-14. 24. Do the health-care workers gain protection against herpes zoster infection? A 6-year population-based study in Taiwan. Wu CY, Hu HY, Huang N, Pu CY, Shen HC, Chou YJ. J Dermatol. 2010;37(5):463-70. 25. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Gupta G, Lautenbach E, Lewis JD. Clin Gastroenterol Hepatol. 2006;4(12):1483-90. 26. Racial and psychosocial risk factors for herpes zoster in the elderly. Schmader K, George LK, Burchett BM, Pieper CF. J Infect Dis. 1998;178(Suppl 1):S67-70. 27. Risk factors for postherpetic neuralgia in patients with herpes zoster. Jung BF, Johnson RW, Griffin DR, Dworkin RH. Neurology. 2004;62:1545-51. 28. Association of primary cutaneous amyloidosis with atopic dermatitis: a nationwide population-based study in Taiwan. Lee DD, Huang CK, Ko PC, Chang YT, Sun WZ, Oyang YJ. Br J Dermatol. 2011;164(1):148-53. 29. Split Selection Methods for Classification Tree. Loh WY, Shih YS. Statistica Sinica 1997;7:815-40. 30. MEDock: a web server for efficient prediction of ligand binding sites based on a novel optimization algorithm. Chang DT, Oyang YJ, Lin JH. Nucleic acids research 2005;33:W233-8. 31. Application of data mining techniques to healthcare data. Obenshain MK. Infect Control Hosp Epidemiol. 2004;25:690-5. 32. Application of a data-mining technique to analyze co-prescription patterns for antacids in Taiwan. Chen TJ, Chou LF, Hwang SJ. Clinical therapeutics.2003;25:2453-63. 33. Comorbidity study of ADHD: applying association rule mining (ARM) to National Health Insurance Database of Taiwan. Tai YM, Chiu HW. International journal of medical informatics. 2009;78:e75-83. 34. Intelligent heart disease prediction system using data mining techniques. Palaniappan S, Awang R. In IEEE/ACS International Conference on Computer Systems and Applications; March 31-April 4. 2008:108-15. 35. Prediction of chronic obstructive pulmonary disease (COPD) in asthma patients using electronic medical records. Himes BE, Dai Y, Kohane IS, Weiss ST, Ramoni MF. J Am Med Inform Assoc 2009;16:371-9. 36. Prediction of clinical behaviour and treatment for cancers. Futschik ME, Sullivan M, Reeve A, Kasabov N. Applied bioinformatics 2003;2:S53-8. 37. Current developments in the analysis of proteomic data: Artificial neural network data mining techniques for the identification of proteomic biomarkers related to breast cancer. Lancashire LJ, Mian S, Ellis IO, Rees RC, Ball GR. Current Proteomics 2005;2:15-29. 38. Data mining techniques for cancer detection using serum proteomic profiling. Li L, Tang H, Wu Z, Gong J, Gruidl M, Zou J, Tockman M, Clark RA. Artificial intelligence in medicine 2004;32:71-83. 39. Characterization of digital medical images utilizing support vector machines. Maglogiannis IG, Zafiropoulos EP. BMC medical informatics and decision making 2004;4:4. 40. Efficacy of interferon treatment for chronic hepatitis C predicted by feature subset selection and support vector machine. Yang J, Nugroho AS, Yamauchi K, Yoshioka K, Zheng J, Wang K, Kato K, Kuroyanagi S, Iwata A. Journal of medical systems 2007;31:117-23. 41. Patient Fall Detection using Support Vector Machines. Doukas C, Maglogiannis I, Tragas P, Liapis D, Yovanof G. In Artificial Intelligence and Innovations: from Theory to Applications. Volume 247. Edited by Boukis C, Pnevmatikakis A, Polymenakos L: Springer Boston; 2007:147-56. 42. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Charlson ME, Pompei P, Ales KL, MacKenzie CR. J Chron Dis 1987;40:373-83. 43. Comorbidity measures for use with administrative data. Elixhauser A, Steiner C, Harris DR, Coffey RM. Medical care 1998;36:8-27. 44. How to measure comorbidity. a critical review of available methods. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. J Clin Epidemiol. 2003;56(3):221-9. 45. Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Goldstein LB, Samsa GP, Matchar DB, Horner RD. Stroke. 2004;35(8):1941-5. 46. Charlson comorbidity index adjustment in intracerebral hemorrhage. Bar B, Hemphill JC 3rd. Stroke. 2011;42(10):2944-6. 47. The application of comorbidity indices to predict early postoperative outcomes after laparoscopic Roux-en-Y gastric bypass: a nationwide comparative analysis of over 70,000 cases. Shin JH, Worni M, Castleberry AW, Pietrobon R, Omotosho PA, Silberberg M, Østbye T. Obes Surg. 2013;23(5):638-49. 48. PCA versus LDA. Martinez, A. M.; Kak, A. C. IEEE Transactions on Pattern Analysis and Machine Intelligence. 2001;23:228–33. 49. Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. A. Hata, M. Kuniyoshi, Y. Ohkusa. Infection. 2011;39(6):537–44. 50. Effect of uremia on structure and function of immune system. Vaziri ND, Pahl MV, Crum A, Norris K. J Ren Nutr. 2012;22(1):149-56. 51. Chronic infections and coronary heart disease: is there a link? Danesh J, Collins R, Peto R. Lancet. 1997;350:430-6. 52. Association between herpetic burden and chronic ischemic heart disease: matched case-control study. Esteban-Hernández J, San Román Montero J, Gil R, Anegón M, Gil A. Med Clin (Barc). 2011;137(4):157-60. 53. The effect of iron deficiency anemia on the function of the immune system. Ekiz C, Agaoglu L, Karakas Z, Gurel N, Yalcin I. Hematol J. 2005;5(7):579-83. 54. On the design of optimization algorithms for prediction of molecular interactions. Chang DTH, Lin JH, Hsieh CH, Oyang YJ. Int J Artif Intell Tools. 2010;19(3):267–80. 55. Increased incidence of herpes zoster among patients with systemic lupus erythematosus. Chakravarty EF, Michaud K, Katz R, Wolfe F. Lupus. 2013;22(3):238-44. 56. Cost effectiveness of herpes zoster vaccine in Canada. Najafzadeh M, Marra CA, Galanis E, Patrick DM. Pharmacoeconomics. 2009;27(12):991-1004. 57. Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands. van Lier A, van Hoek AJ, Opstelten W, Boot HJ, de Melker HE. BMC Health Serv Res. 2010;10:237. 58. Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium. Bilcke J, Marais C, Ogunjimi B, Willem L, Hens N, Beutels P. Vaccine. 2012;30(3):675-84. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/6445 | - |
dc.description.abstract | 帶狀疱疹是台灣常見的疾病之一,許多患者還受到其併發症--疱疹後神經痛所苦。雖然已有許多帶狀疱疹的危險因子被報告過,例如紅斑性狼瘡,但大部份報告都只針對單一疾病。近年來機器學習演算法已被大量應用於大型醫學資料庫之分析且獲致極有價值之訊息。本研究針對台灣之全民健康保險研究資料庫,利用兩種特性相異之機器學習演算法--「決策樹」及「線性元件分析」,同時對多種危險因子進行全面性的分析。我們首先以線性鑑別分析法進行特徵選擇,並找出最具相關性的八種共病:心律不整、缺乏性貧血、腎衰竭、類風濕性關節炎、冠狀動脈心臟病、惡性腫瘤、慢性肺病及風濕性疾病。這八種疾病皆以線性元件分析方法加以整合分析,而後四種疾病則用於建構決策樹分析。除了一個末端節點外,所有決策樹之末端節點及線性元件分析之不等式皆得到有意義之勝算比及百分之九十五信賴區間,顯示這兩個方法皆有能力識別出部分罹患帶狀疱疹之高危險群。其中兩個末端節點及四個不等式甚至得到大於三之勝算比,這些患者具有較多次因惡性腫瘤、風濕性疾病、冠狀動脈心臟病或腎衰竭的就診紀錄。我們發現有一群患者可以同時被決策樹及線性元件分析找到,特別是風濕性疾病或冠狀動脈心臟病。線性元件分析可以找到決策樹所無法鑑別的一群腎衰竭患者。雖然決策樹與線性元件分析所識別的帶狀疱疹患者有所重疊,卻也有部分互斥,對於不同族群具有相異之鑑別力,能夠以互補的方式識別出不同族群,因此聯集這兩個演算法之結果或可增加識別之靈敏度。 | zh_TW |
dc.description.abstract | Herpes zoster is a relatively common disorder in Taiwan and many patients suffer from its most notorious complication-- postherpetic neuralgia. A lot of risk factors of herpes zoster have been reported, e.g., systemic lupus erythematosus, but most of the observations were based on one single disorder. In this study, rather than focusing on a specific risk factor, we conducted comprehensive analyses on the joint effects of multiple risk factors based on the National Health Insurance Research Database in Taiwan. In recent years, machine learning algorithms have been applied to the analyses of large medical databases and have yielded valuable information. In this respect, we employed two machine learning algorithms with distinctive characteristics, decision tree and linear component analysis. We first performed feature selection by linear discriminant analysis and identified the most relevant eight comorbidities of herpes zoster, i.e. arrhythmia, deficiency anemia, renal failure, rheumatoid arthritis, coronary heart disease, malignancy, chronic pulmonary disease, and rheumatologic disease; all of them were used in linear component analysis while the last four disorders were incorporated to generate the decision tree. All leaf nodes except for one of decision tree and all inequalities of linear component analysis corresponded to a significant odds ratio and 95% confidence interval, indicating that both methods were able to identify some sub-populations of patients with higher risk of developing herpes zoster. Two leaf nodes of decision tree and four inequalities of linear component analysis yielded odds ratios even higher than 3. Those patients showed more visits for malignancy, rheumatologic disorder, coronary heart disease or renal failure. We noticed a very specific subgroup of patients, especially those of rheumatologic disorder or coronary heart disease, could be identified by both decision tree and linear component analysis algorithms at the same time while linear component analysis discovered cases of renal failure that decision tree was unable to recognize. Though there were overlaps of cases identified by some leaf nodes of decision tree and inequalities of linear component analysis, some extent of exclusions also existed between the herpes zoster cases identified by both algorithms. It implied that decision tree and linear component analysis were able to recognize different populations of herpes zoster cases in a complementary way and therefore union of the results obtained by both methods could possibly increase the sensitivity. | en |
dc.description.provenance | Made available in DSpace on 2021-05-16T16:29:47Z (GMT). No. of bitstreams: 1 ntu-102-D93922024-1.pdf: 3980355 bytes, checksum: b55e5f44f8a72018b49348e1ddac7013 (MD5) Previous issue date: 2013 | en |
dc.description.tableofcontents | 致謝-------------------------------------------------------i中文摘要--------------------------------------------------ii
Abstract--------------------------------------------------iv Table of Contents-----------------------------------------vi List of Figures-----------------------------------------viii List of Tables--------------------------------------------ix 1.Motivation-----------------------------------------------1 2.Background-----------------------------------------------3 2.1 Introduction of herpes zoster--------------------------3 2.1.1 Etiology---------------------------------------------3 2.1.2 Complications----------------------------------------9 2.1.3 Incidence-------------------------------------------12 2.1.4 Risk factors----------------------------------------12 2.1.5 Prevention------------------------------------------16 2.2 Introduction of National Health Insurance Research Database--------------------------------------------------17 2.3 Introduction of machine learning algorithms-----------18 2.3.1 Decision tree---------------------------------------19 2.3.2 Linear component analysis---------------------------20 2.3.3 Rank-based adaptive mutation evolutionary algorithm-20 2.4 Application of machine learning algorithms to large medical databases-----------------------------------------24 3. Materials and Methods----------------------------------27 3.1 Case definition and control selection-----------------27 3.2 Diseases utilized as potential risk factors-----------27 3.3 Feature selection by linear discriminant analysis-----30 3.4 Machine learning algorithms---------------------------30 3.4.1 Decision tree--------------------------------------31 3.4.2 Linear component analysis and RAME -----------------31 3.5 Statistical Analysis----------------------------------32 4. Results------------------------------------------------33 4.1 Demographic data--------------------------------------33 4.2 Univariate analysis-----------------------------------33 4.3 Linear discriminant analysis -------------------------34 4.4 Decision tree-----------------------------------------36 4.5 Linear component analysis-----------------------------39 4.6 Analysis of cases identified by decision tree and/or by linear component analysis------------------------------42 4.6.1 Leaf nodes 6 & 10 of DT-----------------------------42 4.6.2 Inequalities 4, 5, 7 and 9 of LCA------------------ 43 4.6.3 DT and LCA validates each other---------------------43 4.6.4 DT and LCA is complementary to each other-----------44 5. Discussion---------------------------------------------47 6. Conclusions-------------------------------------------53 7. Future Work--------------------------------------------55 References------------------------------------------------57 | |
dc.language.iso | en | |
dc.title | 應用機器學習演算法識別罹患帶狀疱疹之高危險群 | zh_TW |
dc.title | Applying Machine Learning Algorithms to Identify Patients with High Risk of Developing Herpes Zoster | en |
dc.type | Thesis | |
dc.date.schoolyear | 101-2 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 趙坤茂,孫維仁,黃乾綱,陳倩瑜 | |
dc.subject.keyword | 帶狀疱,疹,危險因子,全民健康保險研究資料庫,機器學習演算法,決策樹,線性元件分析, | zh_TW |
dc.subject.keyword | herpes zoster,risk factor,National Health Insurance Research Database,machine learning algorithm,decision tree,linear component analysis, | en |
dc.relation.page | 63 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2013-08-18 | |
dc.contributor.author-college | 電機資訊學院 | zh_TW |
dc.contributor.author-dept | 資訊工程學研究所 | zh_TW |
顯示於系所單位: | 資訊工程學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-102-1.pdf | 3.89 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。